Siblings 會議論文/會議摘要 [23/37] 專利 [0/70] Collection Statistics 近3年內發表的文件:11(6.83%) 含全文筆數:161(100.00%) 文件下載次數統計 下載大於0次:161(100.00%) 下載大於100次:155(96.27%) 檔案下載總次數:89383(86.91%) 最後更新時間: 2025-04-25 23:00 Top Upload Loading... Top Download Loading... Recent Submissions Orally bioavailable and site-select... Natural fucoidans inhibit coronavir... Integrating ultrabright polymer dot... Advancing precision therapy for col... DBPR116, a prodrug of BPRMU191, in ... Discovery of a mu-opioid receptor m... Discovery of a long half-life AURKA... Postfermented tea extract potently ... Natural fucoidans inhibit coronavir... Development of furanopyrimidine-bas...

Jump to a point in the index: (Choose year) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-10 of 161. (17 Page(s) Totally) 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page

Date	Title	Relation
2025-02-27	Orally bioavailable and site-selective covalent STING inhibitor derived from a macrocyclic marine diterpenoid	Journal of Medicinal Chemistry. 2025 Feb 27;Article in Press.
2025-02	Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin[Erratum:Biochemical Pharmacology. 2023 Jul 20;215:Article number 115688.]	Biochemical Pharmacology. 2025 Feb;232:Article number 116753.
2025-01-05	Integrating ultrabright polymer dots and stereo NIR-II imager for assessing anti-angiogenic drugs in oral cancer model	Journal of Cellular and Molecular Medicine. 2025 Jan 05;29(1):Article number e70324.
2025-01	Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models	Pharmacological Research. 2025 Jan;211:Article number 107556.
2024-11-21	Discovery of a mu-opioid receptor modulator that in combination with morphinan antagonists induces analgesia	Cell Chemical Biology. 2024 Nov 21;31(11):1885-1898.e10.
2024-11	DBPR116, a prodrug of BPRMU191, in combination with naltrexone as a safer opioid analgesic than morphine via peripheral administration	Journal of Medicinal Chemistry. 2024 Nov 14;67(21):19777-19790.
2024-06-01	Discovery of a long half-life AURKA inhibitor to treat MYC-amplified solid tumors as a monotherapy and in combination with everolimus	Molecular Cancer Therapeutics. 2024 Jun 01;23(6):766-779.
2024-02-16	Postfermented tea extract potently alleviates glucose metabolism disorders in vitro and in vivo	ACS Food Science and Technology. 2024 Feb 16;4(2):479-490.
2023-07-20	Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin	Biochemical Pharmacology. 2023 Jul 20;215:Article number 115688.
2023-02-07	Development of furanopyrimidine-based orally active third-generation EGFR inhibitors for the treatment of non-small cell lung cancer	Journal of Medicinal Chemistry. 2023 Feb 7;66(4):2566-2588.

Showing items 1-10 of 161. (17 Page(s) Totally) 1 2 3 4 5 6 7 8 9 10 > >> View [10|25|50] records per page